nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—posterior vena cava—abdominal aortic aneurysm	0.346	0.382	CbGeAlD
Dabigatran etexilate—F2—leg—abdominal aortic aneurysm	0.114	0.125	CbGeAlD
Dabigatran etexilate—F2—hindlimb—abdominal aortic aneurysm	0.101	0.112	CbGeAlD
Dabigatran etexilate—F2—artery—abdominal aortic aneurysm	0.0622	0.0687	CbGeAlD
Dabigatran etexilate—F2—blood plasma—abdominal aortic aneurysm	0.0467	0.0515	CbGeAlD
Dabigatran etexilate—UGT1A9—kidney—abdominal aortic aneurysm	0.0292	0.0323	CbGeAlD
Dabigatran etexilate—F2—connective tissue—abdominal aortic aneurysm	0.0248	0.0274	CbGeAlD
Dabigatran etexilate—UGT2B7—kidney—abdominal aortic aneurysm	0.0236	0.026	CbGeAlD
Dabigatran etexilate—CES2—kidney—abdominal aortic aneurysm	0.0236	0.026	CbGeAlD
Dabigatran etexilate—CES1—connective tissue—abdominal aortic aneurysm	0.0228	0.0252	CbGeAlD
Dabigatran etexilate—F2—kidney—abdominal aortic aneurysm	0.0211	0.0234	CbGeAlD
Dabigatran etexilate—NQO2—kidney—abdominal aortic aneurysm	0.0211	0.0233	CbGeAlD
Dabigatran etexilate—CES2—spinal cord—abdominal aortic aneurysm	0.0184	0.0203	CbGeAlD
Dabigatran etexilate—F2—spinal cord—abdominal aortic aneurysm	0.0165	0.0182	CbGeAlD
Dabigatran etexilate—NQO2—spinal cord—abdominal aortic aneurysm	0.0164	0.0181	CbGeAlD
Dabigatran etexilate—ABCB1—blood plasma—abdominal aortic aneurysm	0.01	0.0111	CbGeAlD
Dabigatran etexilate—ABCB1—kidney—abdominal aortic aneurysm	0.00455	0.00502	CbGeAlD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—LDLR—abdominal aortic aneurysm	0.00388	0.041	CbGpPWpGaD
Dabigatran etexilate—ABCB1—spinal cord—abdominal aortic aneurysm	0.00354	0.00391	CbGeAlD
Dabigatran etexilate—F2—Regulation of IGF Activity by IGFBP—MMP2—abdominal aortic aneurysm	0.00327	0.0346	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—SERPINE1—abdominal aortic aneurysm	0.00326	0.0345	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—LDLR—abdominal aortic aneurysm	0.00316	0.0334	CbGpPWpGaD
Dabigatran etexilate—F2—Cell surface interactions at the vascular wall—SELL—abdominal aortic aneurysm	0.00313	0.0331	CbGpPWpGaD
Dabigatran etexilate—F2—Blood Clotting Cascade—SERPINE1—abdominal aortic aneurysm	0.00309	0.0327	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—CCL2—abdominal aortic aneurysm	0.00309	0.0327	CbGpPWpGaD
Dabigatran etexilate—CES2—E2F transcription factor network—CDKN2A—abdominal aortic aneurysm	0.00305	0.0322	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—AGTR1—abdominal aortic aneurysm	0.00296	0.0313	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—LDLR—abdominal aortic aneurysm	0.00251	0.0265	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—SOD2—abdominal aortic aneurysm	0.00245	0.0259	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—MMP9—abdominal aortic aneurysm	0.00221	0.0234	CbGpPWpGaD
Dabigatran etexilate—F2—IL1 and megakaryotyces in obesity—NFKB1—abdominal aortic aneurysm	0.00219	0.0231	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—APOE—abdominal aortic aneurysm	0.00201	0.0213	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—SOD2—abdominal aortic aneurysm	0.002	0.0211	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—SERPINE1—abdominal aortic aneurysm	0.00192	0.0203	CbGpPWpGaD
Dabigatran etexilate—CES1—E2F transcription factor network—CDKN2A—abdominal aortic aneurysm	0.0018	0.019	CbGpPWpGaD
Dabigatran etexilate—F2—Syndecan-4-mediated signaling events—MMP9—abdominal aortic aneurysm	0.00176	0.0186	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—CCL2—abdominal aortic aneurysm	0.00169	0.0179	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—MMP2—abdominal aortic aneurysm	0.00163	0.0173	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—SOD2—abdominal aortic aneurysm	0.00159	0.0168	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—SERPINE1—abdominal aortic aneurysm	0.00158	0.0167	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—P2RY12—abdominal aortic aneurysm	0.00148	0.0157	CbGpPWpGaD
Dabigatran etexilate—F2—Complement and Coagulation Cascades—SERPINE1—abdominal aortic aneurysm	0.0014	0.0148	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—CCL2—abdominal aortic aneurysm	0.00138	0.0145	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—SERPINE1—abdominal aortic aneurysm	0.00128	0.0136	CbGpPWpGaD
Dabigatran etexilate—F2—Angiopoietin receptor Tie2-mediated signaling—NFKB1—abdominal aortic aneurysm	0.00122	0.0128	CbGpPWpGaD
Dabigatran etexilate—F2—Vitamin B12 Metabolism—NFKB1—abdominal aortic aneurysm	0.0012	0.0126	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—P2RY12—abdominal aortic aneurysm	0.00112	0.0119	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—CCL2—abdominal aortic aneurysm	0.00109	0.0115	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—AGTR1—abdominal aortic aneurysm	0.00103	0.0109	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—SERPINE1—abdominal aortic aneurysm	0.00102	0.0108	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—AGTR1—abdominal aortic aneurysm	0.00102	0.0108	CbGpPWpGaD
Dabigatran etexilate—F2—Folate Metabolism—NFKB1—abdominal aortic aneurysm	0.000973	0.0103	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—abdominal aortic aneurysm	0.000923	0.00975	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—PTGS2—abdominal aortic aneurysm	0.000891	0.00941	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—P2RY12—abdominal aortic aneurysm	0.000855	0.00904	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SELL—abdominal aortic aneurysm	0.000849	0.00897	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—AGT—abdominal aortic aneurysm	0.000841	0.00889	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—abdominal aortic aneurysm	0.000823	0.0087	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—abdominal aortic aneurysm	0.000822	0.00869	CbGpPWpGaD
Dabigatran etexilate—F2—Selenium Micronutrient Network—NFKB1—abdominal aortic aneurysm	0.000773	0.00817	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—P2RY12—abdominal aortic aneurysm	0.000765	0.00808	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—AGT—abdominal aortic aneurysm	0.000726	0.00767	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—AGT—abdominal aortic aneurysm	0.000717	0.00758	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—AGTR1—abdominal aortic aneurysm	0.000715	0.00755	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—AGTR1—abdominal aortic aneurysm	0.000683	0.00722	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—abdominal aortic aneurysm	0.000649	0.00686	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—CCL2—abdominal aortic aneurysm	0.00059	0.00624	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AAAS—abdominal aortic aneurysm	0.000589	0.00623	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—abdominal aortic aneurysm	0.000567	0.00599	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—NOS2—abdominal aortic aneurysm	0.00053	0.0056	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—AGTR1—abdominal aortic aneurysm	0.00052	0.0055	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—LDLR—abdominal aortic aneurysm	0.000514	0.00544	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—SERPINE1—abdominal aortic aneurysm	0.000488	0.00516	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—P2RY12—abdominal aortic aneurysm	0.000483	0.00511	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—AGT—abdominal aortic aneurysm	0.000481	0.00508	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—abdominal aortic aneurysm	0.000446	0.00472	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—P2RY12—abdominal aortic aneurysm	0.000439	0.00464	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—LDLR—abdominal aortic aneurysm	0.000427	0.00452	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—abdominal aortic aneurysm	0.000396	0.00418	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—AGT—abdominal aortic aneurysm	0.000366	0.00387	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CCL2—abdominal aortic aneurysm	0.000302	0.00319	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—NOS2—abdominal aortic aneurysm	0.000299	0.00316	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AGTR1—abdominal aortic aneurysm	0.000294	0.00311	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LRP1—abdominal aortic aneurysm	0.000277	0.00293	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AGT—abdominal aortic aneurysm	0.000272	0.00287	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AAAS—abdominal aortic aneurysm	0.000268	0.00284	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AGTR1—abdominal aortic aneurysm	0.000267	0.00282	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—APOE—abdominal aortic aneurysm	0.000266	0.00281	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—P2RY12—abdominal aortic aneurysm	0.000259	0.00274	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—AGT—abdominal aortic aneurysm	0.000258	0.00272	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000252	0.00266	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—MMP3—abdominal aortic aneurysm	0.000238	0.00252	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—LDLR—abdominal aortic aneurysm	0.000234	0.00248	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—AGT—abdominal aortic aneurysm	0.000226	0.00239	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—APOE—abdominal aortic aneurysm	0.000221	0.00234	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AAAS—abdominal aortic aneurysm	0.000218	0.0023	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000214	0.00226	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CCL2—abdominal aortic aneurysm	0.000212	0.00224	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—LDLR—abdominal aortic aneurysm	0.00021	0.00222	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AGT—abdominal aortic aneurysm	0.000207	0.00219	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—MMP2—abdominal aortic aneurysm	0.000202	0.00213	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NCF1—abdominal aortic aneurysm	0.000196	0.00208	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—LDLR—abdominal aortic aneurysm	0.00019	0.00201	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AGT—abdominal aortic aneurysm	0.000188	0.00199	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—abdominal aortic aneurysm	0.000182	0.00193	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—abdominal aortic aneurysm	0.000167	0.00176	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AGTR1—abdominal aortic aneurysm	0.000158	0.00167	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CCL2—abdominal aortic aneurysm	0.000155	0.00164	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—abdominal aortic aneurysm	0.000152	0.0016	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000145	0.00153	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP3—abdominal aortic aneurysm	0.000141	0.00149	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AGT—abdominal aortic aneurysm	0.000124	0.00131	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—APOE—abdominal aortic aneurysm	0.000121	0.00128	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AGT—abdominal aortic aneurysm	0.000111	0.00117	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APOE—abdominal aortic aneurysm	0.000109	0.00115	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AGT—abdominal aortic aneurysm	0.000101	0.00106	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AAAS—abdominal aortic aneurysm	0.0001	0.00106	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—APOE—abdominal aortic aneurysm	9.86e-05	0.00104	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCL2—abdominal aortic aneurysm	9.14e-05	0.000966	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—LDLR—abdominal aortic aneurysm	8.73e-05	0.000923	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SERPINE1—abdominal aortic aneurysm	8.53e-05	0.000902	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—abdominal aortic aneurysm	8.31e-05	0.000878	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—abdominal aortic aneurysm	6.75e-05	0.000714	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—abdominal aortic aneurysm	6.54e-05	0.000691	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NFKB1—abdominal aortic aneurysm	6.47e-05	0.000684	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AGT—abdominal aortic aneurysm	4.62e-05	0.000488	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—APOE—abdominal aortic aneurysm	4.52e-05	0.000478	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—abdominal aortic aneurysm	3.1e-05	0.000327	CbGpPWpGaD
